Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9199-0.0045 (-0.49%)
At close: 04:00PM EDT
0.8860 -0.03 (-3.69%)
After hours: 07:52PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
126,847
126,325
7,128
144,927
33,215
Operating expenses
Research development
123,593
145,860
172,920
141,891
90,570
Selling general and administrative
80,740
87,744
79,694
69,261
30,775
Total operating expenses
203,848
234,308
253,618
209,420
121,345
Operating income or loss
-77,001
-107,983
-246,490
-64,493
-88,130
Interest expense
15,891
13,176
6,020
2,910
2,924
Total other income/expenses net
2,292
134
-705
-1,045
981
Income before tax
-82,683
-113,724
-250,157
-65,578
-89,127
Income from continuing operations
-82,683
-113,724
-250,157
-65,578
-89,127
Net income
-82,683
-113,724
-250,157
-65,578
-89,127
Net income available to common shareholders
-82,683
-113,724
-250,157
-65,578
-89,127
Basic EPS
-1.11
-
-2.31
-0.72
-1.12
Diluted EPS
-1.11
-
-2.31
-0.72
-1.12
Basic average shares
126,765
-
108,077
91,703
79,789
Diluted average shares
126,765
-
108,077
91,703
79,789